Drug intelligence / Profile preview

DepoDur + lidocaine

Development stage
Unknown
Lead developer
SkyePharma
Modality
Small Molecules
Administration
Epidural
01

Overview

DepoDur + lidocaine represents a specific drug interaction scenario in epidural anesthesia. DepoDur is an extended-release liposomal formulation of morphine sulfate designed for single-dose epidural administration that provides up to 48 hours of post-surgical pain relief. When lidocaine (a local anesthetic) is administered epidurally before DepoDur, it significantly alters DepoDur's pharmacokinetics by increasing the release of morphine from the liposomal carrier. This interaction results in higher peak serum concentrations of morphine and faster time to maximum concentration. Clinical studies have shown that administering DepoDur just 3 minutes after a lidocaine-epinephrine test dose results in approximately 2-3 times higher maximum serum concentration of morphine compared to DepoDur alone. This interaction can be minimized by waiting at least 15 minutes between the lidocaine test dose and DepoDur administration. DepoDur is indicated for the treatment of pain following major surgery, including cesarean section, lower abdominal surgery, and major orthopedic surgery of the lower extremities.

02

Targets

DOR (Opioid Receptor Delta 1)ORM1 (Alpha-1-acid glycoprotein 1)NaV (Voltage-gated sodium channels)MOR (Mu opioid receptor)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on DepoDur + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DepoDur + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call